SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $170,000 | -19.0% | 6,370 | -6.4% | 0.02% | -8.0% |
| Q2 2021 | $210,000 | +11.7% | 6,805 | -5.3% | 0.02% | +13.6% |
| Q1 2021 | $188,000 | +327.3% | 7,183 | +191.0% | 0.02% | +266.7% |
| Q1 2020 | $44,000 | -13.7% | 2,468 | +13.9% | 0.01% | 0.0% |
| Q4 2019 | $51,000 | -15.0% | 2,167 | -0.3% | 0.01% | 0.0% |
| Q3 2019 | $60,000 | +9.1% | 2,173 | +31.5% | 0.01% | 0.0% |
| Q2 2019 | $55,000 | -5.2% | 1,653 | -0.7% | 0.01% | -57.1% |
| Q1 2019 | $58,000 | +18.4% | 1,665 | +12.9% | 0.01% | +16.7% |
| Q4 2018 | $49,000 | -18.3% | 1,475 | +22.9% | 0.01% | 0.0% |
| Q3 2018 | $60,000 | -74.4% | 1,200 | -79.5% | 0.01% | -73.9% |
| Q4 2017 | $234,000 | -12.7% | 5,864 | -12.5% | 0.05% | -4.2% |
| Q3 2017 | $268,000 | +4366.7% | 6,701 | +1356.7% | 0.05% | +4700.0% |
| Q3 2015 | $6,000 | -87.5% | 460 | -89.5% | 0.00% | -75.0% |
| Q2 2014 | $48,000 | +23.1% | 4,380 | 0.0% | 0.00% | +33.3% |
| Q1 2014 | $39,000 | – | 4,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |